文献速递胸部CT

肺癌筛查CT检出的恶性结节:短期随访CT显示结节生长的检出率

Malignant Nodules Detected on Lung Cancer Screening CT: Yield of Short-Term Follow-Up CT in Showing Nodule Growth.
PubMed 文献 · AJR Am J Roentgenol · 2022-06-08

该回顾性研究纳入76例肺癌筛查CT阳性(Lung-RADS≥3类)且后续确诊肺癌、在诊断或治疗干预前至少3个月有随访CT的患者,用半自动软件测量结节直径和体积。恶性结节生长缓慢,3个月随访时线性测量和体积测量分别仅5%和7%显示生长;作者认为3个月稳定不应高估良性可能,将所有此类结节降为Lung-RADS 2类可能有问题。

要点

  • 恶性结节生长缓慢,线性测量中位生长时间13个月、体积测量11个月。
  • 3个月随访显示生长的比例线性测量仅5%、体积测量仅7%。
  • 3个月稳定不应高估良性,将所有稳定结节降为Lung-RADS 2类可能有问题。

核心结论

  • 恶性结节在随访CT上生长缓慢,3个月随访CT显示生长的检出率很低;3个月随访稳定不应高估良性可能,将所有此类结节降为Lung-RADS 2类可能有问题。

研究设计与样本

  • 回顾性研究纳入76例患者(女53例、男23例,中位年龄68岁),均为2015年6月至2021年5月间肺癌筛查CT阳性(Lung-RADS≥3类)、后续确诊肺癌且在诊断或治疗干预前至少3个月有一次随访CT者;采用半自动软件进行线性与体积测量,直径取短轴与长轴测量值的均值。

诊断标准与关键数值

  • 实性结节生长定义为平均直径增加至少1.5 mm或体积增加至少25%;部分实性结节定义为实性成分平均直径增加至少1.5 mm或体积增加至少25%;磨玻璃结节定义为平均直径增加至少3 mm或结节内出现新实性成分。

临床应用与阅片要点

  • 作者认为3个月随访稳定不应高估良性可能,将所有3个月及以上无变化的3类或4类结节降为Lung-RADS 2类可能有问题。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. Lung-RADS recommends 3-month follow-up for category 4A nodules and downgrading to category 2 of all category 3 or 4 nodules that are unchanged for 3 months or longer, indicating benign behavior. This guidance may be problematic considering the potential for slow-growing cancers in that lack of nodule growth, particularly at short follow-up intervals, may provide false reassurance. OBJECTIVE. The purpose of this study was to evaluate the yield of short-term follow-up CT in showing growth among malignant nodules detected on lung cancer screening CT. METHODS. This retrospective study included 76 patients (53 women, 23 men; median age, 68 years) with a positive lung cancer screening CT result (Lung-RADS category ≥ 3) between June 2015 and May 2021 with a subsequent lung cancer diagnosis and at least one follow-up CT examination at least 3 months before diagnostic or therapeutic intervention. Semiautomated software was used for linear and volumetric nodule measurements. Diameter was defined as the mean of short- and long-axis measurements. For solid nodules, growth was defined as an at least 1.5-mm increase in mean diameter or an at least 25% increase in volume; part-solid nodules, an at least 1.5-mm increase in solid-component mean diameter or an at least 25% increase in volume; and ground-glass nodules, an at least 3-mm increase in mean diameter or development of a new solid component within the nodule. RESULTS. Median time to growth was 13 months by linear and 11 months by volumetric measurement. Frequency of growth at 3 months was 5% by linear and 7% by volumetric measurement. By linear measurement, median time to growth and frequency of growth at 3 months were 13 months and 7% (solid nodules), 18 months and 6% (part-solid nodules), not reached and 0% (ground-glass nodules), not reached and 0% (category 3 nodules), 13 months and 6% (category 4A nodule)s, 6 months and 11% (category 4B nodules), and 12 months and 10% (category 4X nodules). CONCLUSION. Malignant nodules manifest growth slowly on follow-up CT, and 3-month follow-up CT has very low yield. Stability at 3-month follow-up should not instill high confidence in benignancy, and downgrading all such nodules to Lung-RADS category 2 may be problematic. CLINICAL IMPACT. This study highlights the possibility of slow-growing malignancy and associated challenges in application of Lung-RADS to management of unchanged nodules on follow-up imaging.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Byrne, Hammer. Malignant Nodules Detected on Lung Cancer Screening CT: Yield of Short-Term Follow-Up CT in Showing Nodule Growth. AJR Am J Roentgenol. 2022. PMID: 35674352. doi:10.2214/AJR.22.27869

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。